AUA 2016 - Prostate Cancer

REVIEW UroToday

Viewing 1-20 of 46 articles

AUA 2016: Baseline prostate atrophy is associated with lower tumor volume in men with prostate cancer on repeat biopsy - Poster Session Highlights

AUA 2016: Pathologic and Biochemical Outcomes among African-American and Caucasian Men with Low-Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy - Poster Session Highlights

AUA 2016: Evaluation of a potency fullness scaler at 3 months is predictive of overall 2 year outcomes after RARP - Poster Session Highlights

AUA 2016: Incidence, risk factors and outcomes for rectal injury during radical prostatectomy - Session Highlights

AUA 2016: Extent of pelvic lymph node dissection in lymph node negative prostate cancer is significant in predicting risk of biochemical recurrence - Session Highlights

AUA 2016: The level of education as independent predictor of overall, non-cancer and second cancer mortality after radical prostatectomy - Session Highlights

AUA 2016: The Influence of Board Certification on Outcomes after Radical Prostatectomy - Poster Session Highlights

AUA 2016: Using a prebiospy checklist to understand risk factors associated with infection-related hospitalization following prostate biopsy - Poster Session Highlights

AUA 2016: The Impact of Infectious Complications after Prostate Biopsy on Radical Prostatectomy Surgical Outcomes: A Population-Based Analysis - Poster Session Highlights

AUA 2016: The Effect of Smoking on 30-Day Morbidity Following Malignancy-Related Prostatectomy - Poster Session Highlights

AUA 2016: BRCA Gene Mutations Associated With Increased Prostate Cancer Risk

AUA 2016: Defining Deliverables of Multiparametric Magnetic Resonance Imaging (mpMRI)/Ultrasound (US) Fusion-Guided Targeted Prostate Biopsy: Actionable Intelligence Metric (AIM) and Reduction Metric (RM) - Session Highlights

AUA 2016: Impact of Abiraterone Acetate in Prostate Specific AntiGEN Trial Update: Effect of abiraterone acetate and low dose prednisone on prostate-specific antigen and radiographic disease progression in patients with nmCRPC

AUA 2016: Study of PSMA-Targeted 18F-DCFPyL PET/CT in the Evaluation of Men with an Elevated PSA Following Radical Prostatectomy - Session Highlights

AUA 2016: Validation of a bone scan positivity risk table in non-metastatic castration-resistant prostate cancer - Session Highlights

AUA 2016: Case Discussion - Non-Metastatic and Asymptomatic Metastatic Castrate Resistant Prostate Cancer - Session Highlights

AUA 2016: What’s Next for Radiation Therapy in Low to Favorable/Intermediate Risk? - Session Highlights

AUA 2016: Ablation Therapy: How To Distinguish Oncologic Efficacy from an Active Surveillance Mimic - Session Highlights

AUA 2016: Eye of the Beholder: Is Delayed Treatment on Active Surveillance a Success or Failure? - Session Highlights

AUA 2016: Repeat Biopsy: State-of-the-Art Patient Selection and Technique - Session Highlights

1
2
3